Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vemurafenib Expanded Access in Metastatic Melanoma
NCT01248936Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vemurafenib in melanoma, sponsored by Roche. Started Dec 2010; status: completed.
02
Drugs
vemurafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01248936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248936.